Viatris Inc (FRA:VIA)
€ 11.935 -0.44 (-3.56%) Market Cap: 14.33 Bil Enterprise Value: 27.28 Bil PE Ratio: 0 PB Ratio: 0.81 GF Score: 66/100

Viatris Inc at Jefferies London Healthcare Conference Transcript

Nov 15, 2023 / 09:30AM GMT
Release Date Price: €8.59 (+1.86%)
Glen Joseph Santangelo
Jefferies LLC, Research Division - Equity Analyst

Good morning, everybody. Thank you for joining us. We're excited to be hosting Viatris here with us today. Joining us from the company is Scott Smith, CEO, gentleman in the middle; to his left, Rajiv Malik, the President; and to Scott's far right over there Sanjeev Narula, the CFO; and Bill Szablewski, (inaudible) who heads Capital Market, he also (inaudible) Investor Relations (inaudible).

Today's format is just going to be a question-and-answer session. So we'll hope we'll try to get through this as fast as possible. For those of you who don't know me, I'm Glen Santangelo, I cover the specialty pharma, company operation, technology sectors at Jefferies and the analyst responsible for coverage of Viatris. So with that why don't we get started.

Questions & Answers

Glen Joseph Santangelo
Jefferies LLC, Research Division - Equity Analyst

Scott it's been an interesting 8 months since you took over as CEO, a lot going on this year. The company transformation really

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot